Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura are both autoimmune conditions leadin
|
This lecture will provide an overview of the burden and outcomes of COVID-19 among patients living with cance
|
Genitourinary malignancies will account for approximately 20% of newly diagnosed cancers in 2021.
|
CAR-T therapy is expanding as a therapeutic option both in clinical trials and FDA approved commercial produc
|
Wendell Yarbrough, MD, MMHC, FACS,
|
Dr.
|
This lecture is an interactive presentation and discussion to consider barriers to cancer clinical trial enro
|
Dr.
|
Dr. Benyam Muluneh from the UNC Eshelman School of Pharmacy will discuss relevant topics in cancer pharmacy for North Carolina cancer providers, such as adherence to oral anti-cancer therapies, evolving pharmaceutical practice models (e.g. specialized clinics), toxicity measurement and management, access, and other issues.
|
Dr.
|